A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions
Clinical trial NCT00864071 · COMPLETED
Trial details
- NCT number
- NCT00864071
- Sponsor
- Actavis Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2005-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.